| Breakdown | TTM | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 58.83B | 60.11B | 61.74B | 62.18B | 53.17B | 44.72B |
| Gross Profit | 23.81B | 23.84B | 25.31B | 25.74B | 21.50B | 17.52B |
| EBITDA | 8.95B | 9.23B | 9.90B | 11.55B | 9.68B | 7.04B |
| Net Income | 4.64B | 4.68B | 4.91B | 6.75B | 4.84B | 3.09B |
Balance Sheet | ||||||
| Total Assets | 77.02B | 79.00B | 74.91B | 68.95B | 60.51B | 52.84B |
| Cash, Cash Equivalents and Short-Term Investments | 7.26B | 7.97B | 6.39B | 8.19B | 8.14B | 8.10B |
| Total Debt | 13.54B | 14.51B | 11.01B | 6.72B | 5.67B | 4.68B |
| Total Liabilities | 27.39B | 28.47B | 26.17B | 23.27B | 19.53B | 15.56B |
| Stockholders Equity | 49.59B | 50.49B | 48.22B | 45.20B | 39.73B | 35.65B |
Cash Flow | ||||||
| Free Cash Flow | 0.00 | -1.56B | -3.06B | 1.72B | 2.08B | 907.00M |
| Operating Cash Flow | 0.00 | 4.87B | 1.76B | 4.40B | 5.23B | 4.59B |
| Investing Cash Flow | 0.00 | -4.89B | -4.75B | -1.33B | -3.69B | -2.32B |
| Financing Cash Flow | 0.00 | 1.57B | 923.00M | -3.40B | -1.81B | -803.00M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
82 Outperform | ¥19.74B | 7.97 | ― | 0.72% | 6.51% | 3.68% | |
81 Outperform | ¥256.39B | 9.64 | 8.91% | 3.85% | 1.48% | 8.86% | |
78 Outperform | ¥112.14B | 15.71 | ― | 4.64% | 3.99% | -28.28% | |
77 Outperform | ¥90.37B | 8.96 | ― | 3.82% | 3.68% | -46.19% | |
76 Outperform | ¥200.50B | 11.03 | ― | 2.50% | -2.46% | -10.72% | |
67 Neutral | ¥93.90B | 17.07 | ― | 3.77% | -5.87% | 24.10% | |
63 Neutral | $10.79B | 15.43 | 7.44% | 2.01% | 2.89% | -14.66% |